| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $97.1M | -27.3% |
| R&D Expense | $192.1M | -8.7% |
| SG&A Expense | $56.7M | -7.1% |
| Operating Income | -$151.7M | -10.1% |
| Income Tax | $5.2M | +60.2% |
| Net Income | -$130.4M | +2.2% |
| EPS (Basic) | -$1.56 | +3.7% |
| EPS (Diluted) | -$1.56 | +3.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.6M | -51.7% |
| Short-term Investments | $474.3M | -15.1% |
| Current Assets | $565.8M | -22.1% |
| Total Assets | $621.8M | -21.1% |
| Current Liabilities | $177.9M | +89.7% |
| Total Liabilities | $487.7M | -14.9% |
| Stockholders' Equity | $134.2M | -37.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$184.2M | -805.9% |
| Capital Expenditures | $2.4M | -42.2% |
| Investing Cash Flow | $101.9M | +164.1% |
| Financing Cash Flow | $2.5M | -43.5% |
| Free Cash Flow | -$186.5M | -663.1% |